BOIRON SA (BOI.PA) Stock Fundamental Analysis
EPA:BOI - FR0000061129 - Common Stock
23.2 EUR
+0.25 (+1.09%)
Taking everything into account, BOI scores 5 out of 10 in our fundamental rating. BOI was compared to 50 industry peers in the Pharmaceuticals industry. BOI has a great financial health rating, but its profitability evaluates not so good. BOI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
BOI had positive earnings in the past year.
BOI had a positive operating cash flow in the past year.
In the past 5 years BOI has always been profitable.
BOI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BOI has a worse Return On Assets (1.97%) than 62.00% of its industry peers.
With a Return On Equity value of 3.00%, BOI is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
BOI has a Return On Invested Capital of 2.54%. This is in the lower half of the industry: BOI underperforms 62.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BOI is significantly below the industry average of 14.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROIC | 2.54% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
1.3 Margins
Looking at the Profit Margin, with a value of 2.33%, BOI is in line with its industry, outperforming 42.00% of the companies in the same industry.
BOI's Profit Margin has declined in the last couple of years.
BOI has a worse Operating Margin (3.23%) than 60.00% of its industry peers.
BOI's Operating Margin has declined in the last couple of years.
BOI's Gross Margin of 73.58% is fine compared to the rest of the industry. BOI outperforms 66.00% of its industry peers.
BOI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% |
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOI is destroying value.
The number of shares outstanding for BOI remains at a similar level compared to 1 year ago.
The number of shares outstanding for BOI has been reduced compared to 5 years ago.
The debt/assets ratio for BOI is higher compared to a year ago.
2.2 Solvency
BOI has an Altman-Z score of 3.25. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.25, BOI perfoms like the industry average, outperforming 54.00% of the companies in the same industry.
The Debt to FCF ratio of BOI is 0.63, which is an excellent value as it means it would take BOI, only 0.63 years of fcf income to pay off all of its debts.
BOI's Debt to FCF ratio of 0.63 is amongst the best of the industry. BOI outperforms 94.00% of its industry peers.
BOI has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BOI (0.03) is better than 84.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 3.25 |
ROIC/WACC0.33
WACC7.8%
2.3 Liquidity
BOI has a Current Ratio of 2.51. This indicates that BOI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.51, BOI belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
A Quick Ratio of 1.61 indicates that BOI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.61, BOI belongs to the top of the industry, outperforming 82.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
The earnings per share for BOI have decreased strongly by -68.36% in the last year.
BOI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.40% yearly.
Looking at the last year, BOI shows a decrease in Revenue. The Revenue has decreased by -1.15% in the last year.
The Revenue has been decreasing by -2.63% on average over the past years.
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
3.2 Future
Based on estimates for the next years, BOI will show a small growth in Earnings Per Share. The EPS will grow by 2.73% on average per year.
Based on estimates for the next years, BOI will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 35.69 indicates a quite expensive valuation of BOI.
Compared to the rest of the industry, the Price/Earnings ratio of BOI indicates a slightly more expensive valuation: BOI is more expensive than 60.00% of the companies listed in the same industry.
BOI is valuated rather expensively when we compare the Price/Earnings ratio to 27.06, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.03, which indicates a very decent valuation of BOI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BOI indicates a somewhat cheap valuation: BOI is cheaper than 76.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, BOI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.69 | ||
| Fwd PE | 10.03 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BOI is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BOI is valued a bit cheaper than 68.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.25 | ||
| EV/EBITDA | 5.83 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BOI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.45
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.45%, BOI is a good candidate for dividend investing.
BOI's Dividend Yield is rather good when compared to the industry average which is at 3.06. BOI pays more dividend than 94.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, BOI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.45% |
5.2 History
The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
206.77% of the earnings are spent on dividend by BOI. This is not a sustainable payout ratio.
DP206.77%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPA:BOI (9/8/2025, 2:54:37 PM)
23.2
+0.25 (+1.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap407.16M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.45% |
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP206.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.69 | ||
| Fwd PE | 10.03 | ||
| P/S | 0.84 | ||
| P/FCF | 17.25 | ||
| P/OCF | 10.3 | ||
| P/B | 1.08 | ||
| P/tB | 1.57 | ||
| EV/EBITDA | 5.83 |
EPS(TTM)0.65
EY2.8%
EPS(NY)2.31
Fwd EY9.97%
FCF(TTM)1.34
FCFY5.8%
OCF(TTM)2.25
OCFY9.71%
SpS27.78
BVpS21.55
TBVpS14.77
PEG (NY)6.45
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROCE | 3.39% | ||
| ROIC | 2.54% | ||
| ROICexc | 3.01% | ||
| ROICexgc | 4.32% | ||
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% | ||
| FCFM | 4.84% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexcg growth 3Y-33.41%
ROICexcg growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | 0.18 | ||
| Cap/Depr | 37.59% | ||
| Cap/Sales | 3.27% | ||
| Interest Coverage | 14.49 | ||
| Cash Conversion | 68.03% | ||
| Profit Quality | 208.21% | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 3.25 |
F-Score7
WACC7.8%
ROIC/WACC0.33
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-62.79%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.06%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y-13.1%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%